Purpose: To compare patient functional scores and rates of achieving minimum clinically important differences (MCID) and patient acceptable symptomatic state (PASS) between patients with a hypotrophic labrum with those with a normal labrum width at a minimum 1-year follow-up from arthroscopic treatment of femoroacetabular impingement syndrome.
Methods: Data from consecutive patients who underwent primary hip arthroscopy between November 2015 and July 2018 for the treatment of femoroacetabular impingement syndrome were analyzed. Baseline demographic data, preoperative patient-reported outcome measures (PROMs), and minimum 1-year PROMs, including Hip Outcome Score-Activities of Daily Living, Hip Outcome Score-Sports Subscale, modified Harris Hip Score, international Hip Outcome Tool 12 questions, and visual analog scale for pain and satisfaction were recorded. The labrum size was determined using an arthroscopic probe at the 12- to 2-o'clock position with a hypotrophic labrum being defined as <4 mm and normal labrum defined as having a width between 4 and 7 mm on the articular side. Patients with hypotrophic labrum were matched 1:1 by age and body mass index to patients with normal labrum width.
Results: A total of 346 patients were included in the study with an average age of 31.4 ± 11.9 and a majority being female (72.0%). There were 173 in each of the normal and hypotrophic groups. There were no significant differences seen in 1-year PROMs between the 2 groups (P > .05 for all). The normal labrum group achieved MCID at a rate of 75% to 84% and PASS at a rate of 51% to 70%. The hypotrophic labrum group achieved MCID at a rate of 70% to 85% and PASS at a rate of 57% to 71%. There were no significant differences in rates between each group (P > .05 for all).
Conclusions: Patients with an intraoperative finding of labral hypotrophy achieve 1-year meaningful clinical outcome at the same rate as those with normal labral width following arthroscopic labral repair.
Level of evidence: III, Case-control study.
Copyright © 2020. Published by Elsevier Inc.